NCT05723718 MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment
| NCT ID | NCT05723718 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Lublin |
| Condition | Gastric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 125 participants |
| Start Date | 2022-12-20 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 125 participants in total. It began in 2022-12-20 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this single-arm prospective, multicenter, cross-sectional study is to evaluate the nutritional status and body composition on tumor regression grade with bioelectrical impedance analysis in gastric cancer patients undergoing multimodal treatment. Results of this study will reveal whether nutritional status and body composition assessment based on bioelectrical impedance analysis will become a validated and objective tool to support clinical decisions in gastric cancer patients undergoing multimodal treatment.
Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Histologically confirmed gastric adenocarcinoma (or undifferentiated carcinoma) 3. Stage II - III disease (cT2 cN+ and cT3-T4 cN+/-) based on the 8th edition of TNM classification 4. Qualification for multimodal treatment by the decision of the multidisciplinary tumor board Exclusion Criteria: 1. Early gastric cancer (cT1N0-3M0) scheduled for endoscopic treatment by multidisciplinary team 2. Gastric stump carcinoma 3. Distant metastasis 4. Upfront surgery 5. Other malignancies 6. Contraindications to bioelectrical impedance analysis (e.g., implanted cardiac devices, metal implants or pregnancy)
Contact & Investigator
Zuzanna Pelc, PhD
PRINCIPAL INVESTIGATOR
Medical University of Lublin
Frequently Asked Questions
Who can join the NCT05723718 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Gastric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05723718 currently recruiting?
Yes, NCT05723718 is actively recruiting participants. Contact the research team at zuzannapelc@umlub.pl for enrollment information.
Where is the NCT05723718 trial being conducted?
This trial is being conducted at Lublin, Poland.
Who is sponsoring the NCT05723718 clinical trial?
NCT05723718 is sponsored by Medical University of Lublin. The principal investigator is Zuzanna Pelc, PhD at Medical University of Lublin. The trial plans to enroll 125 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.